MR Spectroscopy
Showing 1 - 25 of 3,328
Asmd, Visceral Type Trial in Amsterdam (MR Spectroscopy (MRS), MR Elastography (MRE))
Recruiting
- Asmd, Visceral Type
- MR Spectroscopy (MRS)
- MR Elastography (MRE)
-
Amsterdam, Noord-Holland, NetherlandsAmsterdam UMC
Jun 6, 2023
Post COVID-19 Condition, Somatic Symptom Disorder Trial in Innsbruck (yoga, social contact)
Recruiting
- Post COVID-19 Condition
- Somatic Symptom Disorder
- yoga
- social contact
-
Innsbruck, Tirol, AustriaMedizinische Universität Innsbruck
Jul 13, 2023
Patient Outcome Assessment Trial (hyperpolarized 13C-labeled pyruvate from dynamic nuclear polarization (DNP) magnetic resonance
Not yet recruiting
- Patient Outcome Assessment
- hyperpolarized 13C-labeled pyruvate from dynamic nuclear polarization (DNP) magnetic resonance spectroscopy
- (no location specified)
Oct 26, 2022
Glioma, Gliomas, High Grade Glioma Trial run by the National Cancer Institute (NCI) (3T MRI scanner)
Recruiting
- Glioma
- +4 more
- 3T MRI scanner
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Feb 2, 2023
Magnetic Resonance Spectroscopy Trial in Bern (NIMM_MRS)
Recruiting
- Magnetic Resonance Spectroscopy
- NIMM_MRS
-
Bern, PhD, SwitzerlandTranslational Imaging Center
Jun 7, 2022
Brain Metastases Trial in Toronto (Hyperpolarized 13C-Pyruvate)
Recruiting
- Brain Metastases
- Hyperpolarized 13C-Pyruvate
-
Toronto, Ontario, CanadaSunnybrook Health Sciences Centre
May 4, 2022
MR Imaging and MR Spectroscopy of HIV
Recruiting
- HIV Infections
-
Los Angeles, CaliforniaUniversity of California, Los Angeles
May 16, 2022
Clinical Development of MR Spectroscopy and Imaging in Brain
Completed
- Malignant Gliomas
- +2 more
- 3 Tesla Scanning
- 7 Tesla Scanning
-
Dallas, TexasUT Southwestern Medical Center
Jan 19, 2022
X-linked Hypophosphatemia Trial in New Haven (Burosumab Injection [Crysvita])
Completed
- X-linked Hypophosphatemia
- Burosumab Injection [Crysvita]
-
New Haven, ConnecticutYale University School of Medicine
Oct 7, 2022
Benign Breast Tumor, Breast Carcinoma, Malignant Breast Tumor Trial in Los Angeles (Diffusion Weighted Imaging, Magnetic
Completed
- Benign Breast Neoplasm
- +2 more
- Diffusion Weighted Imaging
- Magnetic Resonance Spectroscopic Imaging
-
Los Angeles, CaliforniaUCLA / Jonsson Comprehensive Cancer Center
Oct 13, 2023
Alzheimer, Magnetic Resonance Spectroscopy, Ultra High Field 7T Trial (MRI follow-up)
Not yet recruiting
- Alzheimer Disease
- +4 more
- MRI follow-up
- (no location specified)
Jun 30, 2023
Brain Tumor Adult Trial in Salt Lake City (MR Perfusion Scan, 2HG Spectroscopy Scan)
Active, not recruiting
- Brain Tumor Adult
- MR Perfusion Scan
- 2HG Spectroscopy Scan
-
Salt Lake City, UtahHuntsman Cancer Institute
Nov 21, 2022
Magnetic Resonance (MR) Spectroscopy of Breast Cancer Tissue
Terminated
- Breast Neoplasms
-
Trondheim, NorwayNorwegian University of Technology and Science
Mar 18, 2021
Breast Cancer, Neuroendocrine Tumors, Neuroendocrine Carcinoma Trial in Copenhagen (18F-FDG, Injection of hyperpolarized
Enrolling by invitation
- Breast Cancer
- +3 more
- 18F-FDG
- +2 more
-
Copenhagen, DenmarkRigshospitalet
Jan 18, 2023
Recurrent World Health Organization (WHO) Grade II Glioma, Recurrent WHO Grade III Glioma, WHO Grade II Glioma Trial in San
Recruiting
- Recurrent World Health Organization (WHO) Grade II Glioma
- +3 more
- Hyperpolarized Carbon C 13 Pyruvate
- +2 more
-
San Francisco, CaliforniaUniversity of California, San Francisco
Dec 21, 2022
Autism Spectrum Disorder Trial in Columbia (Memantine, Magnetic Resonance Imaging)
Completed
- Autism Spectrum Disorder
- Memantine
- Magnetic Resonance Imaging
-
Columbia, MissouriUniversity of Missouri
Apr 9, 2021
F-18-Fluorocholine PET/CT and MR Imaging/ Spectroscopy in
Completed
- Prostate Cancer
-
Lausanne, CH, SwitzerlandCentre Hospitalier Universitaire Vaudois
Jul 22, 2021
Prostate Adenocarcinoma, Prostate Cancer Trial in San Francisco (Hyperpolarized Carbon C 13 Pyruvate, Magnetic Resonance
Recruiting
- Prostate Adenocarcinoma
- Prostate Cancer
- Hyperpolarized Carbon C 13 Pyruvate
- +2 more
-
San Francisco, CaliforniaUniversity of California, San Francisco
Oct 3, 2022
NAFLD Among Patients With Type 2 Diabetes and CKD
Completed
- Non-Alcoholic Fatty Liver Disease
- +2 more
- Magnetic resonance (MR) spectroscopy of the liver
- +5 more
-
Copenhagen, DenmarkDepartment of Nephrology
Aug 31, 2021
Malignant Brain Glioma Trial in Atlanta (Magnetic Resonance Spectroscopic Imaging, Proton Therapy)
Recruiting
- Malignant Brain Glioma
- Magnetic Resonance Spectroscopic Imaging
- Proton Therapy
-
Atlanta, Georgia
- +2 more
May 27, 2022
Left Ventricular Dysfunction Trial in Saint Louis (MR Spectroscopy)
Completed
- Left Ventricular Dysfunction
- MR Spectroscopy
-
Saint Louis, MissouriWashington University in St. Louis
Jul 22, 2020
MRI and PET Imaging in Predicting Treatment Response in Stage
Active, not recruiting
- Cervical Adenocarcinoma
- +12 more
- Computed Tomography
- +5 more
-
Miami, Florida
- +5 more
Oct 4, 2022
Healthy Trial in Irvine (onabotulinumtoxinA)
Completed
- Healthy
-
Irvine, CaliforniaUniversity of California, Irvine
May 15, 2020
Hepatic Encephalopathy, Liver Cirrhosis Trial in New Haven (Flumazenil, Placebo)
Withdrawn
- Hepatic Encephalopathy
- Liver Cirrhosis
- Flumazenil
- Placebo
-
New Haven, ConnecticutYale Psychological Medicine Research Center
Jul 3, 2020
Fatty Liver, Fatty Liver, Nonalcoholic Trial in Seoul (Quantitative US (Samsung Medison, RS85A))
Completed
- Fatty Liver
- Fatty Liver, Nonalcoholic
- Quantitative US (Samsung Medison, RS85A)
-
Seoul, Korea, Republic ofSeoul National University Hospital
Mar 3, 2022